Pathogenicity of feline leukemia virus is commonly associated with variant viruses.
Many of the serious diseases resulting from feline leukemia virus (FeLV) infection are associated with the generation of novel variant viruses. The prototype FeLV-A virus is highly stable and circulates in the cat population without apparent antigenic change. However, recombination with cellular oncogenes produces viruses which cause leukemia or other malignant diseases. Other recombinants within the env genes of FeLV-A and endogenous FeLV are recognized as belonging to a second subgroup, FeLV-B, the presence of which is correlated with an increased risk of infection with FeLV and a higher incidence of leukemia. Mutants of FeLV which affect the env gene are phenotypically of a third subgroup, FeLV-C, and have a close association with erythroid aplasia. None of these viruses, apart from FeLV-B, is transmitted further in nature. Therefore the generation of these novel viruses and the production of disease is an inadvertent consequence of FeLV infection.
Jarrett
O
O
University of Glasgow, Department of Veterinary Pathology, Bearsden, Scotland.
D000740:Anemia / Q000382:microbiology / Q000662:veterinary; D000818:Animals; D002415:Cats; D005354:Fibrosarcoma / Q000235:genetics / Q000662:veterinary; D015752:Genes, env / Q000235:genetics*; D005256:Leukemia Virus, Feline / Q000145:classification / Q000235:genetics / Q000472:pathogenicity*; D016582:Leukemia, Feline / Q000150:complications / Q000382:microbiology*; D008223:Lymphoma / Q000235:genetics / Q000662:veterinary; D009154:Mutation / Q000235:genetics; D009857:Oncogenes; D011995:Recombination, Genetic / Q000235:genetics*